Meta-analysis and prospective meta-analysis in childhood leukemia clinical research

Annals of Oncology

Volumn 7, Issue 10, 1996, Pages 1009-1014

  Shuster, J J ^a   Gieser, P W ^a  

^a University of Florida ^*  (United States)

Author keywords

acute lymphoblastic leukemia; fixed effects; meta analysis; random effects; randomization

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030481350     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010492     Document Type: Review

References (127)

1. Valsecchi MG, Masera G. A new challenge in clinical research in childhood ALL: The prospective meta-analysis strategy for inter-group collaboration. Ann Oncol 1996; 7: 1005-8 (this issue).
2. Glass G. Primary, secondary, and meta-analysis of research. Educ Res 1976; 5: 3-9.
3. Boissel J, Blanchard J, Panak E et al. Considerations for the meta-analysis of randomized clinical trials, Controlled Clin Trials 1989; 10: 254-81.
4. Peto R. Why do we need systematic overviews of randomized trials? Statist Med 1987; 6: 233-44.
5. Chalmers TC. Meta-analysis in clinical medicine. Trans Am Clin Climato Assoc 1987; 99: 144-50.
6. Simon R. The role of overviews in cancer therapeutics. Stat Med 1987; 6: 389-96.
7. Bulpitt CJ. Meta-analysis. Lancet 1988; 2: 93-4.
8. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224-233.
9. Sacks HS, Berrier J, Reitman D et al. Meta-analyscs of randomized controlled trials. N Engl J Med 1987; 316: 450-5.
10. Chalmers TC. Problems induced by meta-analyses (disc: P979-980). Stat Med 1991; 10: 971-9.
11. Mosteller F, Chalmers TC. Some progress and problems in meta-analysis of clinical trials. Stat Sci 1992; 7: 227-36.
12. Wachter KW. Disturbed by meta-analysis? Science 1988; 241: 1407-8.
13. Thompson SG, Pocock SJ. Can meta-analyscs be trusted? Lancet 1991; 338: 1127-30.
14. Goodman S. Have you ever meta-analysis you didn't like? Ann Intern Med 1991; 114: 244-6.
15. Mann C. Meta-analysis in the breech. Science 1990; 249: 476-80.
16. Mann C. Can meta-analysis make policy? Science 1994; 266: 960-2.
17. Armitage P. Controversies and achievements in clinical trials. Controlled Clin Trials 1984; 5: 67-72.
18. Bailey KR. Inter-study differences: How should they influence the interpretation and analysis of results? Stat Med 1987; 6: 351-60.
19. Begg CB, Pilote L. A model for incorporating historical controls into a meta-analysis. Biometrics 1991; 47: 899-906.
20. Berlin JA, Laird NM, Sacks HS et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989; 8: 141-51.
21. Berry DA. A Bayesian approach to multicentcr trials and meta-analysis. ASA Proc Biopharmaceut Section. Washington DC: American Statistical Association 1990; 1-10.
22. Brand R, Kragt H. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 1992; 11: 2077-82.
23. Brown MB. A method for combining non-independent, onesided tests of significance (corr: V32 p955). Biometrics 1975; 31:987-92.
24. Canner PL. An overview of six clinical trials of aspirin in coronary heart disease. Stat Med 1987; 6: 255-67.
25. Carlin JB. Meta-analysis for 2 × 2 tables: A Bayesian approach. Stat Med 1992; 11: 141-58.
26. Carroll RJ, Stefanski LA. Measurement error, instrumental variables and corrections for attenuation with applications to meta-analyses. Stat Med 1994; 13: 1265-82.
27. Chalmers TC, Berrier J, Sacks HS et al. Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree. Stat Med 1987; 6: 733-44.
28. Chalmers TC, au, J. Meta-analytic stimulus for changes in clinical trials. Stat Methods Med Res 1993; 2: 161-72.
29. Chalmers TC, Levin H, Sacks HS et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. Stat Med 1987; 6: 315-28.
30. Collins R, Gray R, Godwin J et al. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviews. Stat Med 1987; 6: 245-54.
31. Cook TD, Cooper H, Cordray DS et al. Meta-Analysis for Explanation: A Casebook. Russell Sage Foundation 1992.
32. Dear KBG. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50: 989-1002.
33. Dear KBG, Begg CB. An approach for assessing publication bias prior to performing a meta-analysis. Stat Sci 1992; 7: 237-45.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-88.
35. Dickerson K, Higgins K, Meinert C. Identification of metaanalyses: The need for standard terminology. Controlled Clin Trials 1990; 11: 52-66.
36. Dubey SD. Regulatory considerations on meta-analysis, dentifrice studies and multiccnter trials. In ASA Proceedings of Biopharmaceutical Section. Washington DC: American Statistical Association 1988; 18-27.
37. Eddy DM, Hasselblad V, Shachter R. Meta-Analysis by the Confidence Profile Method. The Statistical Synthesis of Evidence. Boston: Academic Press 1991.
38. Emerson JD, Hoaglin DC, Mosteller F. A modified randomeffect procedure for combining risk difference in sets of 2 × 2 tables from clinical trials. J Italian Stat Soc 1993; 269-90.
39. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2: 121-45.
40. Friedman MA. Potential pooling opportunities: Cancer. Stat Med 1987; 6: 307-14.
41. Furberg CD, Morgan TM. Lessons from overviews of cardiovascular trials. Stat Med 1987; 6: 295-306.
42. Gelber RD. Goldhirsch A. Interpretation of results from subset analyses within overviews of randomized clinical trials. Stat Med 1987; 6: 371-80.
43. Goodman SN. Meta-analysis and evidence (com: P205-208). Controlled Clin Trials 1989; 10: 188-204.
44. Green SJ, Fleming TR, Emerson S. Effects on overviews of early stopping rules for clinical trials. Stat Med 1987; 6: 361-9.
45. Halvorsen KT, Burdick E, Colditz GA et al. Combining results from independent investigations: Meta-analysis in clinical research. In Bailar III JC, Mosteller F (eds): Medical Uses of Statistics (second edition). Boston 1992; 413-26.
46. Hedges LV. How hard is hard science, how soft is soft science? The empirical cumulativeness of research. Am Psychol 1987; 42: 443-55.
47. Hedges LV. Comments on 'Methodologic issues in overviews of randomized clinical trials'. Stat Med 1987; 6: 381-8.
48. Hedges LV Meta-analysis. In Encyclopedia of Statistical Sciences 1989; (9 vols, plus supplement) 5: 96-8.
49. Hedges LV, Meta-analysis. J Educ Behav Statist 1992; 17: 279-96.
50. Hedges LV, Cooper H, Bushman BJ. Testing the null hypothesis in meta-analysis: A comparison of combined probability and confidence interval procedures. Psychol Bull 1992; 111: 188-94.
51. Hedges LV, Olkin I. Nonparametric estimators of effect size in meta-analysis. Psychol Bull 1984; 96: 573-80.
52. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando: Academic Press 1985.
53. Hennekens CH, Buring JE, Hebert PR. Implications of overviews of randomized trials. Stat Med 1987; 6: 397-409.
54. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Stat Med 1993; 12: 2273-84.
55. Hughes MD, Freedman LS, Pocock SJ. The impact of stopping rules on heterogeneity of results in overviews of clinical trials. Biometrics 1992; 48: 41-53.
56. Hunter JE, Schmidt FL. Methods of Meta-Analysis. Correcting Error and Bias in Research Findings. Newbury Park: Sage Publications 1989.
57. Huque MF. Experiences with meta-analysis in NDA submissions. In ASA Proceedings of Biopharmaceutical Section. Washington DC: American Statistical Association 1988; 28-33.
58. Huque MF, Dubey SD. A meta-analysis methodology for utilizing study-level covariate information from clinical trials. Communications in Statistics, Part A. Theory and Methods 1994; 23: 377-94.
59. Irwig L, Tosteson ANA, Gatsonis C et al. Guidelines for metaanalyses evaluating diagnostic tests. Ann Intern Med 1994; 120: 667-76.
60. Iyengar S, Much ado about meta-analysis. Chance, New Directions for Statistics and Computers 1991; 4: 33-40.
61. Katz BM, Marascuilo LA, McSweeney M. Nonparametric alternatives for testing main effects hypotheses: A model for combining data across independent studies. Psychol Bull 1985; 98: 200-8.
62. Kelly A. Meta-analysis unconfounded: A case history. The Statistician 1993; 42: 275.
63. Kilpatrick SJ. Environmental tobacco smoke and lung cancer: A critique of a meta-analysis. The Statistician 1992; 41: 331.
64. Kimball KT. Meta-analysis. In ASA Conference on Radiation and Health VIII. Washington DC: American Statistical Association 1990; 93-7.
65. Koch GG, Schmid JE, Begun JM et al. Meta-analysis of drug safety data. In Sogliero-Gilbert G (ed): Drug Safety Assessment in Clinical Trials. New York: Dekker 1992; 279-304.
66. Koziol JA, Tuckwell HC. A weighted nonparametric procedure for the combination of independent events. J Math Methods Biosci 1994; 36: 1005-12,
67. Kraemer HC. Theory of estimation and testing of effect sizes: Use in meta-analysis. J Educ Behav Stat 1983; 8: 93-101.
68. Kraemer HC, Andrews G. A nonparametric technique for meta-analysis effect size calculation. Psychol Bull 1982; 91: 404-12.
69. Lau J, Antman EM, Jimenez-Silva J et al. Cumulative metaanalysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-54.
70. Li Y, Shi L, Roth HD. The bias of the commonly-used estimate of variance in meta-analysis. Communications in Statistics, Part A. Theory and Methods 1994; 23: 1063-85.
71. Light RJ. Accumulating evidence from independent studies: What we can win and what we can lose. Stat Med 1987; 6: 221-31.
72. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Cambridge: Harvard University Press 1984.
73. Littell RC, Folks JL. Asymptotic optimality of Fisher's method of combining independent tests (ref: V68 p193-194). J Am Stat Assoc 1971; 66: 802-6.
74. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: A new mcta-analytic method. Med Decision Making 1993; 13: 313-21.
75. Mantel W, Haensel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
76. Maritz JS. Empirical Bayes estimation of the log odds ratio in 2 × 2 contingency tables. Communications in Statistics, Part A. Theory and Methods 1989; 18: 3215-33.
77. McGuire J, Bates GW, Dretzke BJ et al. Methodological quality as a component of meta-analysis. Educ Psychol 1985; 20: 1-5.
78. Meier P. Comments on 'Methodologic issues in overviews of randomized clinical trials'. Stat Med 1987; 6: 329-31.
79. Meinert C. Meta-analysis: Science or religion? Controlled Clin Trials 1989; 10: S257S-S263.
80. Messori A, Rampazzo R. Meta-analysis of clinical trials based on censored end-points: Simplified theory and implementation of the statistical algorithms on a microcomputer. Computer Methods and Programs in Biomedicine 1993; 40: 261-7.
81. Morris CN, Normand SL. Hierarchical models for combining information and for meta-analyses (disc: P335-344). In Bayesian Statistics 4. Proceedings of the Fourth Valencia International Meeting. New York: North-Holland 1992; 321-35.
82. Norton L. Comments on 'Methodologic issues in overviews of randomized clinical trials'. Stat Med 1987; 6: 333-40.
83. Oakes M. The logic and role of meta-analysis in clinical research. Stal Methods Med Res 1993; 2: 147-60.
84. Orwin RG. A fail-safe n for effect size in meta-analysis. J Educ Behav Stat 1983; 8: 157-9,
85. Orwin RG, Cordray DS. Effects of deficient reporting on meta-analysis: A conceptual framework and reanalysis. Psychol Bull 1985; 97: 134-47.
86. Patil GP, Taillie C. Probing encountered data, meta-analysis and weighted distribution methods. In Dodge Y (ed): Statistical Data Analysis and Inference. New York: North-Holland 1989; 317-45.
87. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. Methods for Quantitative Synthesis in Medicine. New York: Oxford University Press 1994.
88. Pocock SJ, Hughes MD. Estimation issues in clinical trials and overviews. Stat Mcd 1990; 9: 657-71.
89. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. N Engl J Med 1987; 317: 426-32.
90. Radhakrishna S. Combination of results from several 2 × 2 contingency tables. Biometrics 1965; 21: 86-98.
91. Raju NS, Normand J, Burke MJ, Langlois GM. A new metaanalytic approach. J Appl Psychol 1991; 76: 432-46.
92. Raudenbush SW, Bryk AS. Empirical Bayes meta-analysis. J Educ Behav Stat 1985; 10: 75-98.
93. Rockette HE. What evidence is needed to link lung cancer and second-hand smoke? Chance, New Directions for Statisties and Computers 1993; 6: 15-8.
94. Rogatko A. Bayesian approach for meta-analysis of controlled clinical trials. Communications in Statistics. Part A. Theory and Methods 1992; 21: 1441-62.
95. Rosenthal R, Rubin DB. Meta-analytic procedures for combining studies with multiple effect sizes. Psychol Bull 1986; 99: 400-6.
96. Sacks HS, Berrier J, Reitman D el al. Meta-analyses of randomized control trials: An update of the quality and methodology. In Bailar III JC, Mosteller F (cds): Medical Uses of Statistics (second edition). Boston 1992; 427-42.
97. Saris WE, van Meurs AE. Evaluation of Measurement Instruments by Meta-analysis of Multitrait Multimethod Studies. New York: Elscvier/North-Holland 1990.
98. Schmidt FL. What do data really mean? Research findings, meta-analysis, and cumulative knowledge in psychology. Am Psychol 1992; 47: 1173-81.
99. Schmid JE, Koch GG, LaVange LM. An overview of statistical issues and methods of meta-analysis. J Biopharm Stat 1992; 1: 103-20.
100. Simes RJ. Confronting publication bias: A cohort design for meta-analysis. Stat Med 1987; 6: 11-29.
101. Skinner JB. On the combination of studies with repealed measures. In ASA Proceedings of Biopharmaccutical Section. Washington DC: American Statistical Association 1992; 230-3.
102. Spector PE, Levine EL. Meta-analysis for integrating study outcomes: A Monte Carlo study of its susceptibility to type I and type II errors. J Appl Psychol 1987; 72: 3-9.
103. Spector TD, Thompson SG. The potential and limitations of meta-analysis. J Epidemiol Commun Health 1991; 45: 89-92.
104. Srivastava JN. Multivariate analysis with few or incomplete observations. In Rao CR (ed): Multivariate Analysis: Future Directions. New York: North-Holland 1993; 375-400.
105. Stein RA. Meta-analysis from one FDA reviewer's perspective. In ASA Proceedings of Biopharmaceutical Section. Washington DC: American Statistical Association 1988; 34-8.
106. Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of eslrogen use: The role of study design in meta-analysis. Epidemiology 1994; 5: 415-21.
107. Stijnen T, van Houwelingen JC. Empirical Bayes methods in clinical trials meta-analysis. Biometrical J. J Math Methods Biosci 1990; 32: 335-46.
108. Strube MJ. Combining and comparing significance levels from non independent hypothesis tests. Psychol Bull 1985; 97: 334-41.
109. Strube MJ. Power analysis for combining significance levels. Psychol Bull 1985; 98: 595-9.
110. Thacker SB. Meta-analysis: A quantitative approach to research integration. J Am Med Assoc 1988; 259: 1685-9.
111. Thomas H. Effect size standard errors for the non-normal non-identically distributed case. J Educ Behav Stat 1986; 11: 293-303.
112. Thompson SG. Controversies in meta-analysis: The case of the trials of serum cholesterol reduction. Stat Methods Med Res 1993; 2: 173-92.
113. Torri V, Simon R, Russek-Cohen E et al. Statistical model to determine the relationship of response and survival in patients with advanced ovarian cancer treated with chemotherapy. J Natl Cancer Inst 1992; 84: 407-14.
114. Wachter KW, Straf MLE. The Future of Meta-Analysis. New York: Russell Sage Foundation 1990.
115. Walker AM, Martin-Moreno JM, Rodr'iguez Artalejo F. Odd man out: A graphical approach to meta-analysis. Am J Public Health 1988; 78: 961-6.
116. Wanous JP, Sullivan SE, Malinak J. The role of judgment calls in meta-analysis. J Appl Psychol 1989; 74: 259-64.
117. Watanabe H. A Bayesian meta-analysis for reviewing effect sizes. J Psychol Res 1993; 35: 153-6.
118. Whitener EM. Confusion of confidence intervals and credibility intervals in meta-analysis. J Appl Psychol 1990; 75: 315-21.
119. Whitehead A, Jones NMB. A meta-analysis of clinical trials involving different classifications of response into ordered categories. Stat Med 1994; 13: 2503-15.
120. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-77.
121. Wittes RE. Problems in the medical interpretation of overviews. Stat Med 1987; 6: 269-80.
122. Yaroshinsky A, Andary J. Scale heterogeneity and nonparametric meta-analysis of clinical trials data. In ASA Proceedings of Biopharmaceutical Section. Washington DC: American Statistical Association 1993; 34-39.
123. Yusuf S, Obtaining medically meaningful answers from an overview of randomized clinical trials. Stat Med 1987; 6: 281-94.
124. Zeckhauser R. Combining overlapping information. J Am Stat Assoc 1971; 66: 91-2.
125. Zucker D, Yusuf S. Comments on 'Meta-analysis and evidence'. Controlled Clin Trials 1989; 10: 205-8.
126. Childhood ALL Collaborative Group. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukemia: 42 trials involving 12,000 randomised children. Lancet (in press).
127. Smith M, Arthur D, Camitta B et al. A uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1995; 2: 331-7.